Hospital News and Research

RSS

ITDS can be effective for screening fever during H1N1 influenza pandemic: UNMC researchers

Researchers at the University of Nebraska Medical Center found an Infrared Thermal Detection System to be a fast and effective fever screening tool in clinical settings during the H1N1 influenza pandemic. The ITDS detected fever in patients through split-second, non-contact skin temperature measurements.

20 Mar 2010

Hospital News: Insurer negotiations, exemptions at risk, and Florida money trouble

Hospitals are pushing for higher reimbursement rates - in some cases, raises of more than 20 percent - and insurers are increasingly fighting back, The Wall Street Journal reports. "Hospitals argue that low Medicare rates and cuts to Medicaid mean that hospitals have to get money from elsewhere, and increasingly that is private insurers.

20 Mar 2010

Winner of 2010 European Magnetic Resonance Award

Dr John Griffiths, a Cancer Research UK-funded scientist, has received the 2010 European Magnetic Resonance Award for Basic Sciences.

20 Mar 2010

LiftSeat to distribute Hygie Hygienic Cover Systems in the U.S.

LiftSeat Corporation, a leading healthcare toileting solutions company, is now the exclusive distributor in the United States of the Hygie Hygienic Cover System, which is proven to help prevent the spread of potentially fatal healthcare-associated infections. The joint announcement was made today at the Fifth Decennial International Conference on Healthcare-Associated Infections 2010.

20 Mar 2010

Research roundup: Insurance crisis tough on middle class; Hospitals' profit margins on private patients up

Private-Payer Profits Can Induce Negative Medicare Margins - "Hospitals' profit margins on privately insured patients have risen dramatically in recent years, while profit margins on Medicare patients have fallen," write the authors, who all work for MedPAC.

20 Mar 2010

Novus Scientific's TIGR Matrix Surgical Mesh: Initial results of First-in-Man study

Novus Scientific Pte. Ltd today announced the presentation of initial results of the First-in-Man study for TIGR™ Matrix Surgical Mesh. The study results were presented today at the American Hernia Society Meeting in Orlando, Florida by Dr. Fernando Ruiz-Jasbon, Consultant Surgeon at Kungsbacka Hospital / Gothenburg University, Sweden.

20 Mar 2010

Comprehensive community-based solution to help achieve 'meaningful use'

Navigating the Challenges of Meaningful Use to Identify Benefits, March 31, 2010, 2 p.m. CT, a Webinar hosted by Informatics Corporation of America, will explore how to practically implement a community-wide solution that assists its healthcare participants to achieve the proposed American Recovery and Reinvestment Act’s criteria for meaningful use and bridge gaps in the adoption of electronic health records by its provider community.

19 Mar 2010

Call for regionalization of hospital services threat to Cornwall Community, states CUPE

Liberal MPP Jim Brownell's call for the regionalization of hospital services is at best naïve and ignores the threat this poses to the Cornwall Community, CUPE Local 7811, which represents 600 nurses, clerical, maintenance, cleaning, dietary and support staff at the Cornwall Community Hospital said today.

19 Mar 2010

CIO Healthcare Summit to be sponsored by Zanett Healthcare

Zanett Healthcare is pleased to announce that it will sponsor the CIO Healthcare Summit, a leading gathering for CIOs, analysts and industry-thought leaders within healthcare information technology. The CIO Healthcare Summit will be held at the InterContinental Montelucia Resort in Scottsdale, Arizona on May 9-12, 2010.

19 Mar 2010

One-third of patients hospitalized on weekends receive needed major procedures on day of admission

Of the 8 million patients who were admitted to U.S. hospitals on weekends in 2007, approximately one-third received needed major procedures on the day of admission, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In comparison, patients who were admitted on weekdays received 65 percent of all major procedures on their first day in the hospital.

19 Mar 2010

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

Most kidney donors and recipients are in favor of exchanging personal health information that may influence success before scheduling a living organ donor transplant, while healthcare professionals are more reluctant, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

19 Mar 2010

White paper describes health and economic burden of diabetes on Americans

PositiveID Corporation announced today that it has published a white paper entitled “Fixing the Black Hole in Diabetes Management,” which describes the health and economic burden of diabetes on Americans and our economy.

19 Mar 2010

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.

19 Mar 2010

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.

19 Mar 2010

First Edition: March 19, 2010

The headlines reflect yesterday's flurry of activity as House Democratic Leaders unveiled their $940 billion health-care compromise bill and steamed toward a Sunday vote. All the while, Republican leaders plotted was to stall this progress and nullify the measure.

19 Mar 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps). A second study examined endoscopist experience using TER and its impact on polyp detection rates, concluding that polyp detection rates improved significantly with TER.

19 Mar 2010

New report on the state of U.S. mobile health market

CSMG, the strategy division of TMNG Global, a leading provider of professional services, products and services to the converging communications, media and entertainment industries, today released its report on the state of the U.S. mobile health market, entitled: mHealth: Taking the Pulse.

19 Mar 2010

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.

19 Mar 2010

Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-Segment Elevation Myocardial Infarction (STEMI) undergo multi-vessel primary percutaneous coronary intervention (PCI), despite recommendations from the American College of Cardiology and the American Heart Association to intervene on only the culprit vessel.

19 Mar 2010

Study shows that steroids target hemangioma stem cells

Hemangiomas -- strawberry-like birthmarks that commonly develop in early infancy - are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing. Since the 1960s, problematic hemangiomas have been treated with corticosteroids such as dexamethasone or prednisone.

19 Mar 2010

Hospital News and Research

ITDS can be effective for screening fever during H1N1 influenza pandemic: UNMC researchers

Hospital News: Insurer negotiations, exemptions at risk, and Florida money trouble

Winner of 2010 European Magnetic Resonance Award

LiftSeat to distribute Hygie Hygienic Cover Systems in the U.S.

Research roundup: Insurance crisis tough on middle class; Hospitals' profit margins on private patients up

Novus Scientific's TIGR Matrix Surgical Mesh: Initial results of First-in-Man study

Comprehensive community-based solution to help achieve 'meaningful use'

Call for regionalization of hospital services threat to Cornwall Community, states CUPE

CIO Healthcare Summit to be sponsored by Zanett Healthcare

One-third of patients hospitalized on weekends receive needed major procedures on day of admission

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

White paper describes health and economic burden of diabetes on Americans

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

First Edition: March 19, 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

New report on the state of U.S. mobile health market

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

Study shows that steroids target hemangioma stem cells

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News